Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00556387

Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection

Possible Neuroprotective Effects of Ketamine in Children With Severe Traumatic Brain Injury

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
All
Age
1 Month – 16 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the possible effects of an anesthetic agent called Ketamine on the injured brain in children. The researchers think that it will effect the outcomes of children with these injuries.

Conditions

Interventions

TypeNameDescription
DRUGsaline1 mg/kg IV bolus slowly over 1-2 minutes followed by 0.5 mg/kg IV continuous infusion over 48 hours or until discontinuation of ICP monitor (whichever occurs first)
DRUGKetamine1 mg/kg IV bolus slowly over 1-2 minutes, followed by 0.5 mg/kg IV continuous infusion for 48 hours or until discontinuation of ICP monitor (whichever occurs first)

Timeline

Start date
2008-12-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2007-11-12
Last updated
2013-11-01

Source: ClinicalTrials.gov record NCT00556387. Inclusion in this directory is not an endorsement.

Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection (NCT00556387) · Clinical Trials Directory